Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma 260Lymphoma, Non-Hodgkin 205Leukemia, Lymphocytic, Chronic, B-Cell 193Lymphoma, Large B-Cell, Diffuse 187Lymphoma, Follicular 168Lymphoma, Mantle-Cell 134Leukemia 81Lymphoma, B-Cell, Marginal Zone 80Burkitt Lymphoma 54Waldenstrom Macroglobulinemia 52Precursor Cell Lymphoblastic Leukemia-Lymphoma 48Lymphoma, B-Cell 47Lymphoma, Large-Cell, Immunoblastic 42Hodgkin Disease 39Recurrence 35Lymphoma, Large-Cell, Anaplastic 18Multiple Myeloma 16Neoplasms 13Myelodysplastic Syndromes 12Hematologic Neoplasms 12Leukemia, Myeloid, Acute 11Lymphoma, T-Cell 9Intraocular Lymphoma 9Dendritic Cell Sarcoma, Interdigitating 9Leukemia, Prolymphocytic 7Neoplasms, Plasma Cell 6Leukemia, Hairy Cell 6Leukemia, B-Cell 6Graft vs Host Disease 6Arthritis, Rheumatoid 6

Interventions

Radiotherapy 16Amifostine 7Radiotherapy, Intensity-Modulated 6Cisplatin 6Paclitaxel 4Donepezil 4sargramostim 3Radiosurgery 3Low-Level Light Therapy 3Filgrastim 3Etoposide 3Carboplatin 3Surveys and Questionnaires 2Radiation 2Magnetic Resonance Spectroscopy 2Esophagectomy 2Diet Therapy 2Chemotherapy, Adjuvant 2Brachytherapy 2Bevacizumab 2olaparib 1ethanethiol 1delta 24-sterol reductase 1cevimeline 1beta Carotene 1alpha-Tocopherol 1Zinc Sulfate 1Vitamin E 1Vincristine 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Radiation Injuries × Rituximab × Clear all
NCT01399372 2023-07-20

Rituximab, Methotrexate, Vincristine Sulfate, Procarbazine Hydrochloride, and Cytarabine With or Without Radiation Therapy in Treating Patients With Primary Central Nervous System Lymphoma

Radiation Therapy Oncology Group

Phase 2 Completed
91 enrolled 17 charts
Lymphoid

Lymphoma, Radiation Injuries, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡